RE: £ 1 Party , HIKi would come , but wont leave the room.29 Nov 2024 23:29
I have been a shareholder for many years and like most it's cost me money. I jumped back in at just over 1p and sold out at 1.52, the first time I'd ever made money from Hemo.
So I thought I'd give you an outside looking in view, with no bias attached. Whilst it's clear Hemo need money, around £5m I would think, I don't think the SP will remain where it is. Before any raise the letter to authorise trials will arrive. Although it should arrive early next week Vlad did state it could take 3 weeks, I really don't know why he said that? Assuming it is received earlier, the first patient would also be injected before any raise. Therefore any discount would naturally be with a higher SP, in my view probably negating any rise that's made.
But, you then have the current SP with a fully funded Hemo to complete Phase 1 and all the associated benefits if it works.
Potential downside is not receiving the letter promptly (doubtful), a delay in patient recruitment (doubtful) and initial results being poor (which is also doubtful), all imo.
The only other downside I see is a Major not getting involved until Phase 2 which could be someway off.
On the upside and having spoken to Hemo, I would feel confident they'll raise through a single II. I would like to think they'll hold but no guarantees the SP won't initially fall to discount level. But, I still feel it's a great investment opportunity with substantial upside, I'd things work as hoped. I mean you're talking about a product candidate potentially worth billions and still a more exciting trial to start in the spring.
For me, if I can build a decent amount of money and can get back in at under my sell price of 1.52 I'll jump back in to complete the journey. It's a big if so if I don't make it, I really wish all holders well. To make some money would be wonderful, to save a life in the process is priceless.